Clinical Trial Update: Safety Study of CD-NP in Heart Failure [Phase 1]

View source ↗

Summary

Phase 1 safety evaluation of CD-NP in congestive heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• CD-NP (CD-NP)

Snippet

Sponsor: Nile Therapeutics | Conditions: Congestive Heart Failure | Phase 1 | Status: COMPLETED